07:00 , Oct 20, 2014 |  BC Week In Review  |  Company News

Asterand Bioscience, ReproCell deal

ReproCell acquired the induced pluripotent stem cell (iPSC) reagents and services business of Stemgent Inc. , now known as Asterand Biosciences Inc., for about $8.5 million in cash. Asterand will now focus on its human...
07:00 , Aug 6, 2012 |  BC Week In Review  |  Company News

BioSeek, Stemgent deal

BioSeek, formerly Asterand plc , completed the sale of its non-BioSeek Tissue Based Solutions business to Stemgent for $9 million in cash (see BioCentury, July 23). BioSeek plc (LSE:ATD), Royston, U.K.   Stemgent Inc. ,...
07:00 , Jul 23, 2012 |  BC Week In Review  |  Company News

Asterand, Stemgent deal

In June, Stemgent said it will acquire Asterand's non-BioSeek Tissue Based Solutions business for $9 million in cash. At the time, the company also proposed to delist its shares. In a July 13 shareholder circular,...
07:00 , May 7, 2012 |  BC Week In Review  |  Company News

Asterand deal

The tools and tissue-based research services company said that it received notice that a potential bidder will no longer seek acquisition of Asterand's BioSeek Inc. business. Last month, Asterand said that it signed letters of...
07:00 , Apr 30, 2012 |  BioCentury  |  Emerging Company Profile

Ariel: Antagonizing pain

Although standard of care treatments raise safety concerns, along with high rates of non-responders, the pipeline for acute pain continues to be short on novel targets. Ariel Pharmaceuticals Inc. is developing an in-licensed PTGER4 antagonist...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Company News

Asterand, Merck KGaA deal

Asterand's BioSeek LLC subsidiary and Merck's Merck Serono division extended by three years to March 2015 a 2009 deal to use BioSeek's BioMAP systems to evaluate small molecule compounds and proteins from Merck Serono to...
08:00 , Jan 9, 2012 |  BC Week In Review  |  Company News

Asterand functional genomics, admet, supply/service news

The board of the tools and tissue-based research services company extended to Jan. 17 the deadline for submissions of potential offers to acquire all or part of the business. The extension, which will allow potential...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Asterand, Ono Pharmaceutical deal

Asterand's BioSeek LLC subsidiary received an undisclosed milestone payment from Ono under a 2010 deal in which BioSeek is applying its BioMAP human cell-based high throughput assay systems to discover therapeutics against an undisclosed target...
08:00 , Dec 5, 2011 |  BC Week In Review  |  Company News

Asterand functional genomics, admet, supply/service news

The board of the tools and tissue-based research services company extended to early next year its deadline to consider the sale of all or part of the business. The extension will allow potential acquirers more...
07:00 , Oct 31, 2011 |  BC Week In Review  |  Company News

Asterand functional genomics, admet, supply/service news

The board of the tools and tissue-based research services company said it will consider a sale of all or part of the business and began a formal sale process after receiving notices of default from...